Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07227623 · ClinicalTrials.gov registry record · NA

A Digital Health Intervention to Improve Physical Function and Wellness of Lung Cancer Survivors

A NA study of Physical Function and Advanced Lung Cancer, sponsored by Massachusetts General Hospital.

Recruiting
Registry status
NA
Development phase
250
Enrollment target
1
Study location

NCT07227623: Recruiting NA study of Physical Function and Advanced Lung Cancer, sponsored by Massachusetts General Hospital.

NCT07227623 is a NA study of Physical Function and Advanced Lung Cancer that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 250 participants, above the 99-participant average among 8 other Physical Function trials with a reported enrollment target (153% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07227623, a NA study of Physical Function and Advanced Lung Cancer, is actively recruiting participants, sponsored by Massachusetts General Hospital.

RECRUITING
Registry status
NA
Development phase
250 participants
Enrollment target
1
Study location

Study Summary

The rationale for the proposed project is to improve the experience and outcomes of individuals diagnosed with lung cancer treated for cure. Survival rates in patients with stages I-III lung cancer continue to increase given progress in early detection and more effective treatments. However, the survivorship needs of this population are considerable and too often overlooked, especially with respect to their health behaviors, such as physical activity and nutrition, as well as persistent symptoms and side effects, including breathing difficulties and sleep disturbance. To ensure that as many patients as possible can access the information, support, and skills they require to navigate the diagnosis and treatment of lung cancer, the investigators worked with a multidisciplinary team to create a digital health intervention, called "PROMOTE." The investigators designed the PROMOTE mobile app for lung cancer survivors undergoing treatment to help them improve physical function, manage breathlessness and insomnia, increase physical activity, maintain a healthy diet, and enhance their overall wellbeing. To achieve the long-term goal to have PROMOTE become widely available to all lung cancer survivors, the next step in this research program is to conduct a randomized trial to demonstrate the benefits of the digital health intervention. Specifically, the investigators hypothesize that, compared to patients receiving enhanced usual care, those assigned to PROMOTE will report improved physical function, less difficulty with breathlessness and sleep disturbance, increased physical activity, healthier eating behaviors, fewer symptoms of anxiety and depression, and better quality of life. The investigators also plan to examine whether PROMOTE leads to more effective coping and greater confidence in patients' ability to manage their health (i.e., self-efficacy). For this project, the investigators will enroll lung cancer survivors receiving care at an academic cancer center and two

Primary Outcome

To compare patient-reported physical function at 12 weeks using the PROMIS Physical Function 8b Short Form, which is an 8-item measure that evaluates self-perceived capability of one's upper extremities, lower extremities, and activities of daily living (total scale score range: 8-40), with higher scores indicating better functioning.

Interventions

  • BEHAVIORAL Enhanced Usual Care
  • BEHAVIORAL PROMOTE Digital Health App Intervention

Study Locations (1)

Massachusetts

  • Massachusetts General Hospital - Boston

Trial Details

FieldValue
Enrollment Target 250 participants
Start Date 2026-02-06
Est. Completion 2029-02-28
Phase NA
Massachusetts General Hospital

2,032 total trials

What NCT07227623 shows while recruiting

NCT07227623 is an interventional study that assigns participants to a tested intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap, above the 99-participant average among 8 other Physical Function trials with a reported enrollment target (153% higher).

The record links to 2 conditions, with Physical Function appearing as the primary indexed condition, and to 2 interventions - of which Enhanced Usual Care is the first listed.

NCT07227623 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT07227623 about?

NCT07227623 is a clinical study titled "A Digital Health Intervention to Improve Physical Function and Wellness of Lung Cancer Survivors". The rationale for the proposed project is to improve the experience and outcomes of individuals diagnosed with lung cancer treated for cure. Survival rates in patients with stages I-III lung cancer continue to increase given progress in early detection and more effective treatments. However, the sur...

What is the current status of trial NCT07227623?

This trial is currently recruiting. It is a NA study. The enrollment target is 250 participants. The study started on 2026-02-06. Estimated completion is 2029-02-28.

What conditions does trial NCT07227623 study?

This clinical trial studies the following conditions: Physical Function, Advanced Lung Cancer.

What interventions are being tested in trial NCT07227623?

The interventions under investigation include: Enhanced Usual Care (BEHAVIORAL), PROMOTE Digital Health App Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT07227623?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07227623 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Physical Function

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07227623's enrollment target sits among peer trials

250 2nd of 8 the highest of 8 other Physical Function trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Physical Function trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00483249 · 250 participants · NA

    Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm

  • NCT00777712 · 250 participants

    Mechanisms Underlying Impaired Diabetic Wound Healing

  • NCT01451502 · 250 participants · NA

    Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units

  • NCT01771718 · 250 participants

    Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07227623, the US trial registry maintained by the National Library of Medicine. NCT07227623 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.